Quality and outcomes of maternal and perinatal care for 76,563 pregnancies reported in a nationwide network of Nigerian referral-level hospitals.
Jamilu Tukur, Tina Lavin, Abiodun Adanikin...
https://pubmed.ncbi.nlm.nih.gov/35518118/Actively Recruiting
Led by Washington University School of Medicine · Updated on 2026-03-30
1200
Participants Needed
4
Research Sites
52 weeks
Total Duration
Researchers are studying the best ways to develop and use a management package for women with Hypertensive Disorders of Pregnancy HDP in Nigeria. The study aims to find out if a home blood pressure BP monitoring program, tailored for local needs, can improve BP control and cardiovascular health for pregnant women with HDP. This project is conducted at four health institutions in Abuja and Kano, Nigeria. The study has two phases. During the control phase, baseline data like postpartum BP measurements and treatments are recorded. After 12 months, participants switch to the intervention phase where they receive the HDP Implementation Bundle. This bundle includes patient education about BP and HDP risks, training on home BP monitoring with a free automated BP monitor, a standardized follow-up plan, and free antihypertensive medications if needed. Participants will have their BP measured and recorded at enrollment, and again at 6 and 12 weeks postpartum. The study measures differences in systolic and diastolic BP between the control and intervention phases. The researchers will also evaluate how well the program is accepted and followed. This study runs until June 2029, with ongoing monitoring of participants cardiovascular health and BP control.
CONDITIONS
Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria
D
Dike Ojji, MBBS, PhD
K
Kamilu Karaye, MBBS, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Washington University School of Medicine
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants have baseline data collected including postpartum blood pressure measurements and treatment details. Follow-up visits occur to record blood pressure at 6 and 12 weeks postpartum.
Visits at enrollment, 6 weeks, and 12 weeks postpartum
Duration - Up to 12 weeks postpartum
Participants crossover to receive the Hypertensive Disorders of Pregnancy Implementation Bundle, including patient education, home blood pressure monitoring with a provided BP monitor, a standardized follow-up protocol, and provision of free antihypertensive medications if needed.
Daily remote blood pressure reporting and follow-up visits according to the standardized protocol
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jamilu Tukur, Tina Lavin, Abiodun Adanikin...
https://pubmed.ncbi.nlm.nih.gov/35518118/Zainab Mahmoud, Karen E Joynt Maddox, Elena Deych...
https://pubmed.ncbi.nlm.nih.gov/36440578/Emily E Petersen, Nicole L Davis, David Goodman...
https://pubmed.ncbi.nlm.nih.gov/31487273/Kathryn J Lindley, Niti R Aggarwal, Joan E Briller...
https://pubmed.ncbi.nlm.nih.gov/34736568/Vesna D Garovic, Ralf Dechend, Thomas Easterling...
https://pubmed.ncbi.nlm.nih.gov/34905954/Elizabeth A Howell
https://pubmed.ncbi.nlm.nih.gov/29346121/Rachel M Bond, Kecia Gaither, Samar A Nasser...
https://pubmed.ncbi.nlm.nih.gov/33563007/Modele O Ogunniyi, Zainab Mahmoud, Yvonne Commodore-Mensah...
https://pubmed.ncbi.nlm.nih.gov/36302590/Alliance for Maternal and Newborn Health Improvement (AMANHI) mortality study group
https://pubmed.ncbi.nlm.nih.gov/30361107/Emily E Petersen, Nicole L Davis, David Goodman...
https://pubmed.ncbi.nlm.nih.gov/31071074/Washington University School of Medicine
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor